Warren Buffett Abb Vie Inc. Transaction History

Berkshire Hathaway Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $400 Million - $497 Million	-3,033,561 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $1.22 Billion - $1.54 Billion	-11,364,927 Reduced 78.93%	3,033,561 $411 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $652 Million - $740 Million	-6,129,373 Reduced 29.86%	14,398,488 $1.55 Billion
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $246 Million - $274 Million	-2,340,317 Reduced 10.23%	20,527,861 $2.31 Billion
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $273 Million - $300 Million	-2,664,904 Reduced 10.44%	22,868,178 $2.47 Billion
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $344 Million - $464 Million	4,268,766 Added 20.07%	25,533,082 $2.74 Billion
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $1.83 Billion - $2.14 Billion	21,264,316 New	21,264,316 $1.86 Billion

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Berkshire Hathaway Inc, based on Form 13F filings with the SEC.

Stay updated on Berkshire Hathaway Inc and Warren Buffett with notifications on news.